1. Home
  2. AUID vs HCWB Comparison

AUID vs HCWB Comparison

Compare AUID & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$0.89

Market Cap

18.4M

Sector

Technology

ML Signal

HOLD

HCWB

HCW Biologics Inc.

HOLD

Current Price

$4.01

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
HCWB
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
14.8M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
AUID
HCWB
Price
$0.89
$4.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
236.6K
459.2K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
N/A
0.37
Revenue
$2,040,660.00
$4,099,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.35
Revenue Growth
130.20
N/A
52 Week Low
$0.76
$0.25
52 Week High
$4.70
$7.35

Technical Indicators

Market Signals
Indicator
AUID
HCWB
Relative Strength Index (RSI) 34.35 60.85
Support Level N/A $0.37
Resistance Level $1.39 $5.61
Average True Range (ATR) 0.13 0.34
MACD -0.03 -0.09
Stochastic Oscillator 22.60 18.35

Price Performance

Historical Comparison
AUID
HCWB

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: